Junji Tanaka, Norina Tanaka, Yan-Hua Wang, Kenjiro Mitsuhashi, Michiko Ryuzaki, Yuki Iizuka, Aya Watanabe, Midori Ishiyama, Akihito Shinohara, Hiroshi Kazama, Shotaro Hagiwara, Kentaro Yoshinaga, Yumi Kougen, Hirohito Kobayashi, Hitoshi Kanno and Masayuki Shiseki (2020) “Phase I study of cellular therapy using ex vivo expanded natural killer cells from autologous peripheral blood mononuclear cells combined with rituximab-containing chemotherapy for relapsed CD20-positive malignant lymphoma patients”, Haematologica. Pavia, Italy, 105(4), pp. e190-e193. doi: 10.3324/haematol.2019.226696.